| Dr Bashar H Bargoty, MD | |
|
2240 Sutherland Ave, Suite 103, Knoxville, TN 37919-2333 | |
| (865) 588-8831 | |
| (865) 588-8841 |
| Full Name | Dr Bashar H Bargoty |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 23 Years |
| Location | 2240 Sutherland Ave, Knoxville, Tennessee |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780916775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 52587 (Tennessee) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 52587 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Sanders Regional Medical Center | Knoxville, TN | Hospital |
| Parkwest Medical Center | Knoxville, TN | Hospital |
| Physicians Regional Medical Center | Powell, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Statcare Inpatient Llc | 5496025074 | 103 |
| Statcare Outpatient Llc | 2264704055 | 32 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.
It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called "well known scientific experts" have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit's main clinical drug candidate GFT 505.
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
› Verified 9 days ago
| Entity Name | Summit Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.
It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called "well known scientific experts" have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit's main clinical drug candidate GFT 505.
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
› Verified 9 days ago
| Entity Name | Statcare Inpatient Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477086981 PECOS PAC ID: 5496025074 Enrollment ID: O20170714002608 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.
It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called "well known scientific experts" have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit's main clinical drug candidate GFT 505.
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
› Verified 9 days ago
| Entity Name | Statcare Outpatient Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134653892 PECOS PAC ID: 2264704055 Enrollment ID: O20170814001441 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.
It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called "well known scientific experts" have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit's main clinical drug candidate GFT 505.
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bashar H Bargoty, MD Po Box 94670, Oklahoma City, OK 73143-4670 Ph: (405) 682-3303 | Dr Bashar H Bargoty, MD 2240 Sutherland Ave, Suite 103, Knoxville, TN 37919-2333 Ph: (865) 588-8831 |
News Archive
Researchers have identified a set of "molecular signatures" for biliary atresia - the most common diagnosis leading to liver transplant in children - that can help identify the progression of disease at diagnosis and predict clinical outcomes.
The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.
It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called "well known scientific experts" have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit's main clinical drug candidate GFT 505.
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
› Verified 9 days ago
Corey Cudzilo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2240 Sutherland Ave, Suite 103, Knoxville, TN 37919 Phone: 865-588-8831 Fax: 865-588-8841 | |
Dr. Joshua Weber Todd, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1819 W Clinch Ave, Suite 108, Knoxville, TN 37916 Phone: 865-546-5111 Fax: 865-541-4018 | |
Rasmi Ajit, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9330 Park West Blvd Ste 402, Knoxville, TN 37923 Phone: 865-690-3003 Fax: 865-374-2143 | |
Dr. Spencer Pugh, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1924 Alcoa Hwy, Department Of Medicine U-114 Gsm, Utmck, Knoxville, TN 37920 Phone: 865-305-9340 Fax: 865-305-9144 | |
Saji Eapen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 Old Weisgarber Rd, Suite 200, Knoxville, TN 37909 Phone: 865-934-5800 Fax: 865-934-5801 | |
Jeffrey W Robinson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6600 Nightingale Ln, Knoxville, TN 37909 Phone: 865-632-5885 | |
Dr. Mark D Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1928 Alcoa Hwy, B100, Knoxville, TN 37920 Phone: 865-544-6570 Fax: 865-544-6576 |